I agree that this site is using cookies. You can find further informations here.
X
de la Fuente, Macarena I.
190  results:
Search for persons X
?
1

Validation of daily 0.35 T diffusion‐weighted MRI for MRI‐g..:

Lutsik, Natalia ; Nejad‐Davarani, Siamak P. ; Valderrama, Alessandro...
Medical Physics.  , 2024
Link: https://doi.org/10.1002/..
 
?
2

A Deep Learning Approach for Automatic Segmentation during ..:

Breto, Adrian L. ; Cullison, Kaylie ; Zacharaki, Evangelia I....
Cancers.  15 (2023)  21 - p. 5241 , 2023
Link: https://doi.org/10.3390/..
 
?
3

Simulated Adaptive Radiotherapy for Shrinking Glioblastoma ..:

Guevara, Beatriz ; Cullison, Kaylie ; Maziero, Danilo...
Cancers.  15 (2023)  5 - p. 1555 , 2023
Link: https://doi.org/10.3390/..
 
?
4

Delineation of recurrent glioblastoma by whole brain spectr..:

Bell, Jonathan B. ; Jin, William ; Goryawala, Mohammed Z....
Radiation Oncology.  18 (2023)  1 - p. , 2023
Link: https://doi.org/10.1186/..
 
?
5

Olutasidenib (FT-2102) in patients with relapsed or refract..:

de la Fuente, Macarena I ; Colman, Howard ; Rosenthal, Mark...
Neuro-Oncology.  25 (2022)  1 - p. 146-156 , 2022
Link: https://doi.org/10.1093/..
 
?
6

Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurren..:

Mellinghoff, Ingo K. ; Penas-Prado, Marta ; Peters, Katherine B....
Clinical Cancer Research.  27 (2021)  16 - p. 4491-4499 , 2021
Link: https://doi.org/10.1158/..
 
?
7

SNO 2020 diversity survey: defining demographics, racial bi..:

Chukwueke, Ugonma N ; Vera, Elizabeth ; Acquaye, Alvina...
Neuro-Oncology.  23 (2021)  11 - p. 1845-1858 , 2021
Link: https://doi.org/10.1093/..
 
?
8

Ivosidenib, an IDH1 inhibitor, in a patient with recurrent,..:

Tejera, Dalissa ; Kushnirsky, Marina ; Gultekin, Sakir H...
CNS Oncology.  9 (2020)  3 - p. , 2020
Link: https://doi.org/10.2217/..
 
?
9

Resection versus biopsy in the treatment of multifocal glio..:

Di, Long ; Heath, Rainya N. ; Shah, Ashish H....
Journal of Neuro-Oncology.  148 (2020)  1 - p. 155-164 , 2020
Link: https://doi.org/10.1007/..
 
?
10

Short survival and frequent transformation in extranodal ma..:

Alderuccio, Juan Pablo ; Zhao, Wei ; Desai, Amrita...
American Journal of Hematology.  94 (2019)  5 - p. 585-596 , 2019
Link: https://doi.org/10.1002/..
 
?
11

Bilateral radiation therapy followed by methotrexate‐based ..:

Fuente, Macarena I. ; Alderuccio, Juan Pablo ; Reis, Isildinha M....
American Journal of Hematology.  94 (2019)  4 - p. 455-460 , 2019
Link: https://doi.org/10.1002/..
 
?
12

ACTR-52. PHASE 1 STUDY OF FT-2102, AN INHIBITOR OF MUTANT I..:

De la Fuente, Macarena I ; Colman, Howard ; Rosenthal, Mark...
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi25-vi25 , 2019
Link: https://doi.org/10.1093/..
 
?
13

Central nervous system emergencies in haematological malign..:

de la Fuente, Macarena I. ; Alderuccio, Juan Pablo ; Lossos, Izidore S.
British Journal of Haematology.  189 (2019)  6 - p. 1028-1037 , 2019
Link: https://doi.org/10.1111/..
 
?
14

INNV-30. RESPONSE WITH COMBINED DABRAFENIB AND TRAMETINIB A..:

Kushnirsky, Marina ; De la Fuente, Macarena I ; Feun, Lynn
Neuro-Oncology.  21 (2019)  Supplement_6 - p. vi136-vi136 , 2019
Link: https://doi.org/10.1093/..
 
?
15

Chemotherapy for Primary Central Nervous System Lymphoma:

, In: Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy,
De la Fuente, Macarena I. ; Omuro, Antonio M. - p. 455-468 , 2018
Link: https://doi.org/10.1016/..
 
1-15